Literature DB >> 25258678

3-Substituted Biquinolinium Inhibitors of AraC Family Transcriptional Activator VirF from S. flexneri Obtained Through In Situ Chemical Ionization of 3,4-Disubstituted Dihydroquinolines.

Prashi Jain1, Jiaqin Li2, Patrick Porubsky1, Benjamin Neuenswander3, Susan M Egan2, Jeffrey Aubé4, Steven Rogers5.   

Abstract

During a structure-activity relationship optimization campaign to develop an inhibitor of AraC family transcriptional activators, we discovered an unexpected transformation of a previously reported inhibitor that occurs under the assay conditions. Once placed in the assay media, the 3, 4-disubstituted dihydroquinoline core of the active analogue rapidly undergoes a decomposition reaction to a quaternary 3-substituted biquinolinium. Further examination established an SAR for this chemotype while also demonstrating its resilience to irreversible binding of biologically relevant nucleophiles.

Entities:  

Year:  2014        PMID: 25258678      PMCID: PMC4170738          DOI: 10.1039/C4RA08384A

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  22 in total

Review 1.  Soft drug design: general principles and recent applications.

Authors:  N Bodor; P Buchwald
Journal:  Med Res Rev       Date:  2000-01       Impact factor: 12.944

Review 2.  Persistence of antibiotic resistance in bacterial populations.

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

Review 3.  The antibiotic R&D pipeline: an update.

Authors:  Daniela Jabes
Journal:  Curr Opin Microbiol       Date:  2011-08-26       Impact factor: 7.934

4.  Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon.

Authors:  A K Hovey; D W Frank
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

5.  Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF.

Authors:  Veerendra Koppolu; Ichie Osaka; Jeff M Skredenske; Bria Kettle; P Scott Hefty; Jiaqin Li; Susan M Egan
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

Review 6.  Shigellosis.

Authors:  Swapan Kumar Niyogi
Journal:  J Microbiol       Date:  2005-04       Impact factor: 3.422

7.  A comparison of chlorhexidine, cetylpyridinium chloride, triclosan, and C31G mouthrinse products for plaque inhibition.

Authors:  P Renton-Harper; M Addy; J Moran; F M Doherty; R G Newcombe
Journal:  J Periodontol       Date:  1996-05       Impact factor: 6.993

8.  Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.

Authors:  Lynne K Garrity-Ryan; Oak K Kim; Joan-Miquel Balada-Llasat; Victoria J Bartlett; Atul K Verma; Michael L Fisher; Cynthia Castillo; Warangkhana Songsungthong; S Ken Tanaka; Stuart B Levy; Joan Mecsas; Michael N Alekshun
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

9.  A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli.

Authors:  O G Gómez-Duarte; J B Kaper
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Identification of a small-molecule inhibitor of bacterial AraC family activators.

Authors:  Jeff M Skredenske; Veerendra Koppolu; Ana Kolin; James Deng; Bria Kettle; Byron Taylor; Susan M Egan
Journal:  J Biomol Screen       Date:  2013-01-30
View more
  1 in total

1.  Elucidation of Key Interactions between VirF and the virB Promoter in Shigella flexneri Using E. coli MarA- and GadX-Based Homology Models and In Vitro Analysis of the DNA-Binding Domains of VirF and MarA.

Authors:  Nicholas J Ragazzone; Garrett T Dow; George A Garcia
Journal:  J Bacteriol       Date:  2022-08-30       Impact factor: 3.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.